IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $260,000 | -21.7% | 46,433 | +5.4% | 0.00% | 0.0% |
| Q4 2021 | $332,000 | +72.9% | 44,046 | +123.8% | 0.00% | 0.0% |
| Q3 2021 | $192,000 | -31.7% | 19,679 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $281,000 | -73.1% | 19,679 | -55.2% | 0.00% | -71.4% |
| Q1 2021 | $1,043,000 | – | 43,944 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |